Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FLASH Radiotherapy for Skin Cancer

NCT: NCT05724875 · ACTIVE_NOT_RECRUITING

NCT IDNCT05724875
StatusACTIVE_NOT_RECRUITING
Start Date2023-06-22
Completion2026-05

Brief Summary

This is a single center randomized selected Phase II study of FLASH radiotherapy (RT) versus standard of care (SOC) radiotherapy in patients with localized Cutaneous Squamous Cell Carcinoma (cSCC) or Basal Cell Carcinoma (BCC). In summary, the aims of the study are to describe and compare the toxicity and efficacy of high dose rate radiotherapy (FLASH therapy) to SOC conventional radiotherapy (according to the standard guidelines per lesion size) through a randomized Phase II selection study in patients presenting localized cSCC or BCC requiring a radiotherapy treatment.

Frequently Asked Questions

What is FLASH Radiotherapy for Skin Cancer?

FLASH Radiotherapy for Skin Cancer is a clinical trial registered under NCT05724875. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05724875?

The current status of NCT05724875 (FLASH Radiotherapy for Skin Cancer) is: ACTIVE_NOT_RECRUITING.

When did FLASH Radiotherapy for Skin Cancer start?

FLASH Radiotherapy for Skin Cancer started on 2023-06-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.